SE8702188L - Farmaceutiska kompositioner - Google Patents

Farmaceutiska kompositioner

Info

Publication number
SE8702188L
SE8702188L SE8702188A SE8702188A SE8702188L SE 8702188 L SE8702188 L SE 8702188L SE 8702188 A SE8702188 A SE 8702188A SE 8702188 A SE8702188 A SE 8702188A SE 8702188 L SE8702188 L SE 8702188L
Authority
SE
Sweden
Prior art keywords
pharmaceutical compositions
monosaccharide
oral
inter alia
sugar alcohol
Prior art date
Application number
SE8702188A
Other languages
Unknown language ( )
English (en)
Swedish (sv)
Other versions
SE8702188D0 (sv
Inventor
J Vonderscher
J Franz
M Steiger
K Hornung
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH2138/86A external-priority patent/CH667994A5/de
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE8702188D0 publication Critical patent/SE8702188D0/xx
Publication of SE8702188L publication Critical patent/SE8702188L/

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/31—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
SE8702188A 1986-05-27 1987-05-25 Farmaceutiska kompositioner SE8702188L (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH2138/86A CH667994A5 (de) 1986-05-27 1986-05-27 Pharmazeutische zusammensetzungen mit polypeptid-wirkstoffen.
CH214486 1986-05-27

Publications (2)

Publication Number Publication Date
SE8702188D0 SE8702188D0 (sv) 1987-05-25
SE8702188L true SE8702188L (sv) 1987-11-28

Family

ID=25689611

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8702188A SE8702188L (sv) 1986-05-27 1987-05-25 Farmaceutiska kompositioner

Country Status (21)

Country Link
US (1) US5393738A (el)
KR (1) KR870010870A (el)
AU (1) AU601740B2 (el)
BE (1) BE1000722A4 (el)
CA (1) CA1299495C (el)
DE (1) DE3716437A1 (el)
DK (1) DK265587A (el)
ES (1) ES2008126A6 (el)
FI (1) FI872313A7 (el)
FR (2) FR2599254B1 (el)
GB (1) GB2190838B (el)
GR (1) GR870820B (el)
HU (1) HU198626B (el)
IL (1) IL82645A0 (el)
LU (1) LU86901A1 (el)
MY (1) MY101233A (el)
NL (1) NL8701143A (el)
NO (1) NO171484C (el)
NZ (1) NZ220418A (el)
SE (1) SE8702188L (el)
WO (1) WO1987007149A1 (el)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3822557C2 (de) * 1987-07-10 1998-07-02 Ciba Geigy Ag Arzneimittel, enthaltend Somatostatine
GB9013448D0 (en) * 1990-06-15 1990-08-08 Sandoz Ltd Pharmaceutical resorption-improved somatostatin compositions,their preparation and use
FR2668933B1 (fr) * 1990-06-15 1995-05-05 Sandoz Sa Composition pharmaceutique a base de somatostatine.
US5571788A (en) * 1991-12-09 1996-11-05 Ciba-Geigy Corporation Stable calcitonin pharmaceutical compositions
DE19949897A1 (de) * 1999-10-15 2001-04-19 Rainer Rogasch Formkörper und Verfahren zu dessen Herstellung
EP1118333A1 (en) * 2000-01-18 2001-07-25 Eurand International S.P.A. Compositions with enhanced oral bioavailability
ES2383303T3 (es) 2005-11-10 2012-06-20 Chemi S.P.A. Formulaciones de inhibidores de la liberación prolongada de la hormona del crecimiento análogos de la somatostatina
AU2015201581B2 (en) * 2008-09-17 2017-03-09 Amryt Endo, Inc. Pharmaceutical Compositions and Related Methods of Delivery
ES3058497T3 (en) 2008-09-17 2026-03-11 Amryt Endo Inc Pharmaceutical compositions comprising polypeptides and related methods of delivery
WO2011084618A2 (en) 2009-12-16 2011-07-14 Nod Pharmaceuticals, Inc. Compositions and methods for oral drug delivery
US20110142889A1 (en) * 2009-12-16 2011-06-16 Nod Pharmaceuticals, Inc. Compositions and methods for oral drug delivery
US20110182985A1 (en) * 2010-01-28 2011-07-28 Coughlan David C Solid Pharmaceutical Composition with Enhancers and Methods of Preparing thereof
AU2015360485B2 (en) 2014-12-10 2020-06-25 Amryt Endo, Inc. Oral octreotide administered in combination with other therapeutic agents
US10265384B2 (en) 2015-01-29 2019-04-23 Novo Nordisk A/S Tablets comprising GLP-1 agonist and enteric coating
PL3253401T3 (pl) 2015-02-03 2025-08-04 Amryt Endo, Inc. Leczenie akromegalii oktreotydem doustnym
US11141457B1 (en) 2020-12-28 2021-10-12 Amryt Endo, Inc. Oral octreotide therapy and contraceptive methods

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1062898A (en) * 1912-12-09 1913-05-27 Fred Drew Automobile.
GB1062898A (en) * 1963-06-14 1967-03-22 Evans Medical Ltd Pharmaceutical compositions containing protamines
CA959759A (en) * 1970-01-15 1974-12-24 John J. Miskel Method for absorption of drugs
NL167323C (nl) * 1970-09-26 1981-12-16 Organon Nv Werkwijze ter bereiding van een psychofarmacologisch preparaat.
US4179337A (en) * 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
US4041155A (en) * 1974-10-29 1977-08-09 American Home Products Corporation Long acting somatostatin composition
US4151276A (en) * 1975-05-12 1979-04-24 Armour Pharmaceutical Company Method of suppressing gastric acid secretion by the oral administration of calcitonin
CA1098444A (en) * 1975-05-26 1981-03-31 Leo Geller Peptide preparations with prolonged action
NL7607987A (nl) * 1975-08-08 1977-02-10 Merck & Co Inc Werkwijze voor het bereiden van peptiden.
SE7612534L (sv) * 1975-12-01 1977-06-02 Henkel & Cie Gmbh Forfarande for framstellning av farmaceutiska preparat for behandling av storningar i kalciumemnesomsettning
US4093574A (en) * 1977-02-02 1978-06-06 Eli Lilly And Company Somatostatin analogs and intermediates thereto
US4087390A (en) * 1977-02-02 1978-05-02 Eli Lilly And Company Somatostatin analogs and intermediates thereto
DK144731C (da) * 1976-07-30 1982-10-18 Nordisk Insulinlab Fremgangsmaade til isolering af proteinhormoner stammende fra humant hypofysevaev
US4230695A (en) * 1976-08-02 1980-10-28 Vitose Corporation Enhanced protein assimilation with fructose
JPS5920647B2 (ja) * 1976-10-01 1984-05-15 武田薬品工業株式会社 注射剤
US4162248A (en) * 1976-10-14 1979-07-24 Merck & Co., Inc. Somatostatin analogs
GB2008403B (en) * 1977-11-04 1982-07-28 Christie R B Parsons J A Pharmaceutical compositions
CA1107273A (en) * 1978-05-19 1981-08-18 Chester A. Meyers Somatostatin analogs having a substituted tryptophyl residue in position eight
DE3062075D1 (en) * 1979-11-27 1983-03-24 Sandoz Ag Polypeptides, processes for their production, pharmaceutical compositions comprising said polypeptides and their use
JPS56122309A (en) * 1980-03-03 1981-09-25 Teijin Ltd Calcitonin pharmaceutical for rectal administration
JPS57118509A (en) * 1981-01-14 1982-07-23 Toyo Jozo Co Ltd Novel preparation of high absorbability
SE460638B (sv) * 1981-01-14 1989-11-06 Toyo Jozo Kk Suppositoriepreparat med foerbaettrad absorptionsegenskap
JPS57146723A (en) * 1981-03-06 1982-09-10 Toyo Jozo Co Ltd Pharmaceutical preparation having improved absorption
JPS57146722A (en) * 1981-03-06 1982-09-10 Toyo Jozo Co Ltd Pharmaceutical preparation having improved absorption
JPS5885813A (ja) * 1981-11-17 1983-05-23 Toyo Jozo Co Ltd 吸収性良好な製剤
US4900730A (en) * 1981-01-14 1990-02-13 Toyo Jozo Co., Ltd. Preparation which promotes the absorption of peptides
JPS57128634A (en) * 1981-02-03 1982-08-10 Eisai Co Ltd Elastase-containing compound increasing absorption
JPS58500563A (ja) * 1981-04-27 1983-04-14 バクスタ−、トラベノ−ル、ラボラトリ−ズ、インコ−ポレイテツド グルコ−ス、アミノ酸およびインシユリンを含む透析液
AU558474B2 (en) * 1981-07-17 1987-01-29 Nordisk Insulinlaboratorium A stable aqueous, therapeutic insulin preparation and a process for preparing it
US4457916A (en) * 1982-08-31 1984-07-03 Asahi Kasei Kogyo Kabushiki Kaisha Method for stabilizing Tumor Necrosis Factor and a stable aqueous solution or powder containing the same
GB2127689B (en) * 1982-10-05 1986-07-09 Sandoz Ltd Calcitonin inhalation compositions
US4452775A (en) * 1982-12-03 1984-06-05 Syntex (U.S.A.) Inc. Cholesterol matrix delivery system for sustained release of macromolecules
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
EP0164397B1 (en) * 1983-11-21 1990-07-04 The Regents Of The University Of Minnesota A buffered polyol-hormone mixture for use in chronic parenteral hormone administration
JPS6197229A (ja) * 1984-10-18 1986-05-15 Chugai Pharmaceut Co Ltd 安定なエリトロポエチン製剤
JPS61267528A (ja) * 1984-11-26 1986-11-27 Yamanouchi Pharmaceut Co Ltd 吸収促進剤を含有するカルシトニン経鼻剤
US4650787A (en) * 1985-04-25 1987-03-17 Schally Andrew Victor Biologically active octapeptides

Also Published As

Publication number Publication date
FR2599254A1 (fr) 1987-12-04
NL8701143A (nl) 1987-12-16
IL82645A0 (en) 1987-11-30
FR2630916A1 (fr) 1989-11-10
FR2630916B1 (fr) 1993-10-22
FI872313L (fi) 1987-11-28
GB8712193D0 (en) 1987-06-24
SE8702188D0 (sv) 1987-05-25
HUT43956A (en) 1988-01-28
DK265587A (da) 1987-11-28
NO171484B (no) 1992-12-14
LU86901A1 (fr) 1987-12-16
GB2190838A (en) 1987-12-02
BE1000722A4 (fr) 1989-03-21
KR870010870A (ko) 1987-12-18
CA1299495C (en) 1992-04-28
AU7336487A (en) 1987-12-03
FR2599254B1 (fr) 1989-12-01
AU601740B2 (en) 1990-09-20
US5393738A (en) 1995-02-28
FI872313A0 (fi) 1987-05-25
NO872174D0 (no) 1987-05-25
NO872174L (no) 1987-11-30
FI872313A7 (fi) 1987-11-28
NZ220418A (en) 1990-07-26
NO171484C (no) 1993-03-24
DK265587D0 (da) 1987-05-25
DE3716437A1 (de) 1987-12-03
WO1987007149A1 (en) 1987-12-03
HU198626B (en) 1989-11-28
GR870820B (en) 1987-09-25
MY101233A (en) 1991-08-17
GB2190838B (en) 1990-12-12
ES2008126A6 (es) 1989-07-16

Similar Documents

Publication Publication Date Title
SE8702188D0 (sv) Pharmaceutical compositions
IT1226825B (it) Derivati 4' fosfato di glucosidi della epipodofillotossina e relative composizioni farmaceutiche.
IT8522507A0 (it) Composizioni farmaceutiche contenenti glicosidi antraciclinidi.
DE3863963D1 (de) Pharmazeutische zusammensetzungen.
NO881664L (no) Avgivelsessystemer for farmakologiske preparater.
IL82612A0 (en) Imidazoquinolinyl ether derivatives,their preparation and pharmaceutical compositions containing them
DK152287A (da) Farmaceutisk vaginalmiddel
IT8619625A0 (it) Composizioni farmaceutiche per inalazione.
FI863362A7 (fi) Farmaseuttinen koostumus.
DK0526524T3 (da) Farmaceutiske præparater
DE3885670D1 (de) Veretherung von Polyoxyalkylenderivaten.
IT8721411A0 (it) Composizione farmaceutica idrosolubile contenente n acetilsisteina.
NO873534L (no) Stabilt farmasoeytisk gelpreparat.
NL194749B (nl) Stabiel calciumhoudend farmaceutisch preparaat.
NZ220441A (en) Unca-hydrazide-immunoglobulin (glyoprotein) conjugates and pharmaceutical composition
IT8721410A0 (it) Composizione farmaceutica idrosolubile contenente n acetilcisteina.
FI872733A0 (fi) Farmaceutiska kompositioner.
FI883673A7 (fi) Farmaceutiska kompositioner.
IL84795A0 (en) Pharmaceutical compositions comprising ranitidine
DK654888A (da) Farmaceutiske praeprarater indeholdende nedocromilnatrium
DE3866789D1 (de) Pharmazeutische zusammensetzungen.
IT8748554A0 (it) Associazione medicamentosa
IT1216814B (it) Composizioni farmaceutiche
DE3768109D1 (de) Pharmazeutische zusammensetzungen.
IT1214187B (it) Composizioni farmaceutiche antimicotiche.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8702188-7

Effective date: 19941201

Format of ref document f/p: F